Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression

Abstract

Centrosome hyperamplification and the consequential mitotic defects contribute to chromosome instability in cancers. Loss or mutational inactivation of p53 has been shown to induce chromosome instability through centrosome hyperamplification. It has recently been found that Cdk2-cyclin E is involved in the initiation of centrosome duplication, and that constitutive activation of Cdk2-cyclin E results in the uncoupling of the centrosome duplication cycle and the DNA replication cycle. Cyclin E overexpression and p53 mutations occur frequently in tumors. Here, we show that cyclin E overexpression and loss of p53 synergistically increase the frequency of centrosome hyperamplification in cultured cells as well as in tumors developed in p53-null, heterozygous, and wild-type mice. Through examination of cells derived from Waf1-null mice, we further found that Waf1, a potent inhibitor of Cdk2-cyclin E and a major target of p53's transactivation function, is involved in coordinating the initiation of centrosome duplication and DNA replication, suggesting that Waf1 may act as a molecular link between p53 and Cdk2-cyclin E in the control of the centrosome duplication cycle.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bornens M . 1992 The Centrosome Kalnins VI ed New York Academic Press pp 1–43

    Google Scholar 

  • Brinkley BR . 1985 Ann Rev Cell Biol 1: 145–172

  • Carbonaro-Hall D, Williams R, Wu L, Warburton D, Zeichner-David M, MacDougall M, Tolo V and Hall F . 1993 Oncogene 9: 71–79

  • Carroll PE, Okuda M, Horn HF, Biddinger P, Stambrook PJ, Gleich LL, Li Y-Q, Tarapore P and Fukasawa K . 1999 Oncogene 18: 1935–1944

  • Cheng M, Oliver P, Diehl JA, Fero M, Roussel MF, Roberts JM and Sherr CJ . 1999 EMBO J 18: 1571–1583

  • Deng C, Zhang P, Harper JW, Elledge SJ and Leder P . 1995 Cell 82: 675–684

  • Dulic V, Lees E and Reed S . 1992 Science 257: 1958–1961

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . 1993 Cell 75: 817–825

  • Fukasawa K, Murakami M, Blai D, Kuriyama R, Hunt T and Vande Woude GF . 1994 Cell Growth Diff 5: 1093–1103

  • Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF . 1996 Science 271: 1744–1747

  • Fukasawa K, Wiener F, Vande Woude GF and Mai S . 1997 Oncogene 15: 1295–1302

  • Fukasawa K and Vande Woude GF . 1997 Mol Cell Biol 17: 506–518

  • Gannon JV, Greaves R, Iggo R and Lane DP . 1990 EMBO J 9: 1595–1602

  • Girard F, Strausfeld U, Fernandez A and Lamb NJ . 1991 Cell 67: 1169–1179

  • Gu Y, Turck CW and Morgan DO . 1993 Nature 366: 707–710

  • Harlow E and Lane D . 1998 Antibodies a laboratory manual p380, Cold Spring Harbor Laboratory Press

    Google Scholar 

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ . 1993 Cell 75: 805–816

  • Harvey DM and Levine AJ . 1991 Genes Dev 5: 2375–2385

  • Haupt Y, Kazaz A and Oren M . 1997 Nature 387: 296–299

  • Heichman KA and Roberts JM . 1994 Cell 79: 557–562

  • Hickman ES, Bates S and Vousden KH . 1997 J Virol 71: 3710–3718

  • Hinchcliffe EH, Li C, Thompson EA, Maller JL and Sluder G . 1999 Science 283: 851–854

  • Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fern'andez-Salguero PM, Morgan WF, Deng CX and Fornace Jr AJ . 1999 Nat Genet 23: 176–184

  • Hollstein M, Sidransky D, Vogelstein B and Harris CC . 1991 Science 253: 49–53

  • Hsu LC and White RL . 1998 Proc Natl Acad Sci USA 95: 12983–12988

  • Iggo R, Gatter K, Bartek J, Lane D and Harris AL . 1990 Lancet 335: 675–679

  • Joshi HC, Monica JP, McNamara L and Cleveland DW . 1992 Nature 356: 80–83

  • Keyomarsi K and Herliczek TW . 1997 Prog Cell Cycle Res 3: 171–191

  • Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan D, Franza BR and Roberts JM . 1992 Science 257: 1689–1694

  • Kubbutat MH, Jones SN and Vousden K . 1997 Nature 387: 299–303

  • LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E . 1997 Genes Dev 11: 847–862

  • Lacey KR, Jackson PK and Stearns T . 1999 Proc Natl Acad Sci USA 96: 2817–2822

  • Lange BM and Gull K . 1996 Trends Cell Biol 6: 348–352

  • Levine AJ, Momand J and Finlay CA . 1991 Nature 351: 453–456

  • Marraccino RL, Firpo EJ and Roberts JM . 1992 Mol Biol Cell 3: 389–401

  • Martinez J, Georgoff I, Martinez J and Levine AJ . 1991 Genes Dev 5: 151–159

  • Matsumoto T, Hayashi K and Nishida E . 1999 Curr Biol 9: 429–432

  • Mazia D . 1987 Int Rev Cytology 100: 49–92

  • Meraldi P, Lukas J, Fry A, Bartek J and Nigg EA . 1999 Nature Cell Biol 1: 88–93

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ . 1992 Cell 69: 1237–1245

  • Momand J and Zambetti G . 1997 J Cell Biochem 64: 343–352

  • Morgan DO . 1997 Annu Rev Cell Dev Biol 13: 261–291

  • Niculescu III AB, Chen X, Smeet M, Hengst L, Prives C and Reed SI . 1998 Mol Cell Biol 18: 629–643

  • Nowell PC . 1976 Science 194: 23–28

  • Nurse P . 1994 Cell 79: 547–550

  • Ohtsubo M and Roberts JM . 1993 Science 259: 1908–1912

  • Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M . 1995 Mol Cell Biol 15: 2612–2624

  • Oliner JD, Kinzler KW, Meltzer PS, George D and Vogelstein B . 1992 Nature 358: 80–83

  • Oliner JD, Pietenpol JA, Thiagallngam S, Gyuris J, Kinzler KW and Vogelstein B . 1993 Nature 362: 857–860

  • Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G . 1992 EMBO J 11: 961–971

  • Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P and Doxsey SJ . 1998 Cancer Res 58: 3974–3985

  • Reed SI . 1997 Cancer Surv 29: 7–23

  • Resnitzky D, Gossen M, Bujard H and Reed SI . 1994 Mol Cell Biol 14: 1669–1679

  • Rittling SR and Denhardt DT . 1992 Oncogene 7: 935–942

  • Sgambato A, Doki Y, Scheren I and Weinstein IB . 1997 Cell Growth Diff 8: 393–405

  • Sherr CH . 1994 Cell 79: 551–555

  • Sherr CH and Roberts JM . 1995 Genes Dev 9: 1149–1163

  • Spruck CH, Won K-A and Reed SI . 1999 Nature 401: 297–300

  • Stearns T, Evans L and Kirschner M . 1991 Cell 65: 825–836

  • Stillman B . 1996 Science 274: 1659–1664

  • Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H and Okano Y . 1999 Cancer Res 59: 2041–2044

  • Todaro GJ and Green H . 1963 J Cell Biol 17: 299–313

  • Tournier F and Bornens M . 1994 Microtubules Hyams JS and Lloyd CW eds Wiley-Liss New York pp 303–324

    Google Scholar 

  • van der Heuvel S and Harlow E . 1993 Science 262: 2050–2054

  • Vandre DD and Borisy GG . 1989 Mitosis Molecules and Mechanisms Hyams JS and Brinkley BR eds San Diego Academic Press pp 39–75

    Google Scholar 

  • Venkatachalam S, Shi Y-P, Jones NJ, Vogel H, Bradley A, Pinkel D and Donehower LA . 1998 EMBO J 17: 4657–4667

  • Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ and Harris CC . 1999 Proc Natl Acad Sci USA 96: 3706–3711

  • Weber RG, Bridger JM, Benner A, Weisenberger D, Ehemann V, Reifenberger G and Lichter P . 1998 Cytogen Cell Gen 83: 266–269

  • Wimmel A, Lucibello FC, Sewing A, Adolph S and Muller R . 1994 Oncogene 9: 995–997

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D . 1993 Nature 366: 701–704

  • Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T and Deng CX . 1999 Mol Cell 3: 389–395

  • Yewdell JW, Gannon JV and Lane DP . 1986 J Virol 59: 444–452

  • Zhang H, Hannon GJ and Beach D . 1994 Genes Dev 8: 1750–1758

  • Zheng Y, Jung MK and Oakley BR . 1991 Cell 65: 817–823

  • Zhou H, Kuang J, Zhong L, Kuo W, Gray JW, Sahin A, Brinkley BR and Sen S . 1998 Nature Genet 20: 189–193

Download references

Acknowledgements

We thank Dr Philip Leder for Waf1−/− and Waf1+/+ MEFs, Dr Fred Mushinski for the mouse Waf1 cDNA, and Dr George Babcock and Mr Jim Cornelius for flow cytometric analysis. We also thank T Kim, T Hagerty and A Dierkers for technical assistance. We also thank Mr S Tyner for organizing and preparing the tumor samples. This work was supported in part by grants from American Cancer Society, and Cancer Research Challenge and Ruth Lyons Fund.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mussman, J., Horn, H., Carroll, P. et al. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 19, 1635–1646 (2000). https://doi.org/10.1038/sj.onc.1203460

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203460

Keywords

This article is cited by

Search

Quick links